SCHEMBL3943633

SCHEMBL3943633

O=C(Nc1cncc(F)c1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.68
PPARG P37231 3/20 0.68
CYP3A4 P08684 2/20 0.68
MAPK1 P28482 2/20 0.68
ALOX15 P16050 1/20 0.68
PPARA Q07869 1/20 0.68
RORC P51449 8/20 0.64
KMT2A Q03164 5/20 0.64
MEN1 O00255 3/20 0.64
MAPT P10636 3/20 0.64
LMNA P02545 1/20 0.64
TP53 P04637 1/20 0.64
CYP1A2 P05177 1/20 0.64
CYP2D6 P10635 1/20 0.64
CYP2C9 P11712 1/20 0.64
PKM P14618 1/20 0.64
TSHR P16473 1/20 0.64
NFKB1 P19838 1/20 0.64
CYP2C19 P33261 1/20 0.64
THPO P40225 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3944069 0.86 SMN1; SMN2 (0.68) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
SCHEMBL18147812 0.84 RORC (0.76) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
SCHEMBL18146270 0.83 RORC (0.74) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
SCHEMBL3934331 0.83 SMN1; SMN2 (0.64) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
SCHEMBL3937705 0.82 SMN1; SMN2 (0.82) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
SCHEMBL2128178 0.81 SMN1; SMN2 (1.00) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
SCHEMBL29369085 0.81 SMN1; SMN2 (1.00) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
SCHEMBL7130609 0.81 RORC (0.84) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
Hydrochloric Acid SCHEMBL7125284 0.80 SMN1; SMN2 (0.97) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15
SCHEMBL3942317 0.80 JAK2 (0.51) SMN1; SMN2PPARGCYP3A4MAPK1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP disclosed